Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) was the recipient of a large drop in short interest during the month of October. As of October 30th, there was short interest totaling 138,641 shares, a drop of 89.7% from the October 15th total of 1,348,635 shares. Based on an average daily trading volume, of 269,329 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the company’s shares are short sold.
Coloplast A/S Price Performance
Shares of OTCMKTS CLPBY opened at $7.32 on Wednesday. Coloplast A/S has a 1-year low of $5.64 and a 1-year high of $9.50. The business has a 50-day moving average of $6.87 and a 200-day moving average of $6.78. The company has a debt-to-equity ratio of 1.51, a current ratio of 1.56 and a quick ratio of 0.94. The company has a market capitalization of $16.50 billion, a price-to-earnings ratio of 19.33, a PEG ratio of 3.51 and a beta of 0.10.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. The business had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.12 billion. Coloplast A/S had a return on equity of 42.25% and a net margin of 10.57%. On average, equities analysts anticipate that Coloplast A/S will post 0.39 EPS for the current fiscal year.
Analysts Set New Price Targets
Separately, Barclays upgraded Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, November 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Coloplast A/S presently has a consensus rating of “Moderate Buy”.
View Our Latest Report on CLPBY
About Coloplast A/S
Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.
Read More
- Five stocks we like better than Coloplast A/S
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
